John Zalcberg

Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD.

Hans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, Timothy Price, Ralf D Hofheinz, Bernard Nordlinger, Jean-François Daisne, Jos Janssens, Baruch Brenner, Hans Reinel, Stephan Hollerbach, Karel Caca, Florian Fauth, Carla V Hannig, John Zalcberg, Niall Tebbutt, Murielle E Mauer, Sandrine Marreaud, Manfred P Lutz, Karin Haustermans

Journal article  |  2021  |  Journal of Clinical Oncology

PURPOSE: The PETACC 6 trial investigates whether the addition of oxaliplatin to preoperative capecitabine-based chemoradiation and..

Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework

Ashika D Maharaj, Sue M Evans, John R Zalcberg, Liane J Ioannou, Marnie Graco, Daniel Croagh, Charles HC Pilgrim, Theresa Dodson, David Goldstein, Jennifer Philip, James G Kench, Neil D Merrett, Rachel E Neale, Kate White, Peter Evans, Trevor Leong, Sally E Green

Journal article  |  2020  |  PLOS ONE

BACKGROUND: Accurate pre-operative imaging plays a vital role in patient selection for surgery and in allocating stage-appropriate..

Barriers and enablers to the implementation of multidisciplinary team meetings: a qualitative study using the theoretical domains framework.

Ashika D Maharaj, Sue M Evans, John R Zalcberg, Liane J Ioannou, Marnie Graco, Daniel Croagh, Charles HC Pilgrim, Theresa Dodson, David Goldstein, Jennifer Philip, James G Kench, Neil D Merrett, Rachel E Neale, Kate White, Peter Evans, Trevor Leong, Sally E Green

Journal article  |  2020  |  BMJ Quality & Safety

BACKGROUND: Evidence-based clinical practice guidelines recommend discussion by a multidisciplinary team (MDT) to review and plan ..

The short to medium term benefits of the Australian colorectal cancer screening program

Sasha Taylor, Farhad Salimi, Arul Earnest, Alexander G Heriot, John R Zalcberg, Susannah Ahern

Journal article  |  2020  |  Medical Journal of Australia

Facing the Ethical Challenges: Consumer Involvement in COVID-19 Pandemic Research

N Straiton, A McKenzie, J Bowden, A Nichol, R Murphy, T Snelling, J Zalcberg, J Clements, J Stubbs, A Economides, D Kent, J Ansell, T Symons

Journal article  |  2020  |  Journal of Bioethical Inquiry

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

GD Demetri, CR Antonescu, B Bjerkehagen, JVMG Bovee, K Boye, M Chacon, AP Dei Tos, J Desai, JA Fletcher, H Gelderblom, S George, A Gronchi, RL Haas, N Hindi, P Hohenberger, H Joensuu, RL Jones, I Judson, Y-K Kang, A Kawai, et al.

Journal article  |  2020  |  Annals of Oncology

Sarcomas are a heterogeneous group of malignancies with mesenchymal lineage differentiation. The discovery of neurotrophic tyrosin..

Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.

Jing Lou, Sarin Kc, Kai Yee Toh, Saudamini Dabak, Amanda Adler, Jeonghoon Ahn, Diana Beatriz S Bayani, Kelvin Chan, Dechen Choiphel, Brandon Chua, Anne Julienne Genuino, Anna Melissa Guerrero, Brendon Kearney, Lydia Wenxin Lin, Yuehua Liu, Ryota Nakamura, Fiona Pearce, Shankar Prinja, Raoh-Fang Pwu, Asrul Akmal Shafie, et al.

Journal article  |  2020  |  International Journal of Technology Assessment in Health Care

There is growing interest globally in using real-world data (RWD) and real-world evidence (RWE) for health technology assessment (..

Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trial

Suzanne G Orchard, Jessica E Lockery, Peter Gibbs, Galina Polekhina, Rory Wolfe, John Zalcberg, Andrew Haydon, John J McNeil, Mark R Nelson, Christopher M Reid, Brenda Kirpach, Anne M Murray, Robyn L Woods

Journal article  |  2020  |  Contemporary Clinical Trials

BACKGROUND: Cancer is a leading cause of death globally. Given the elevated risk of cancer with age and an ageing population, it i..

Effect of aspirin on cancer incidence and mortality in older adults.

John J McNeil, Peter Gibbs, Suzanne G Orchard, Jessica E Lockery, Wendy B Bernstein, Yin Cao, Leslie Ford, Andrew Haydon, Brenda Kirpach, Finlay Macrae, Catriona McLean, Jeremy Millar, Anne M Murray, Mark R Nelson, Galina Polekhina, Christopher M Reid, Ellen Richmond, Luz Maria Rodríguez, Raj C Shah, Jeanne Tie, et al.

Journal article  |  2020  |  Journal of the National Cancer Institute

BACKGROUND: ASPirin in Reducing Events in the Elderly (ASPREE), a randomized double-blind placebo-controlled trial (RCT) of daily ..

Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.

Jean-Yves Blay, César Serrano, Michael C Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L Jones, Steven Attia, Gina D'Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz-Soto, Suzanne George, Margaret von Mehren

Journal article  |  2020  |  The Lancet Oncology

BACKGROUND: Resistance to approved inhibitors of KIT proto-oncogene, receptor tyrosine kinase (KIT), and platelet-derived growth f..